Amgen (AMGN) Tax Provisions (2009 - 2026)

Amgen's Tax Provisions history runs 18 years deep, the most recent figure standing at $265.0 million for Q1 2026.

• In Q1 2026, Tax Provisions rose 9.05% year-over-year to $265.0 million; the TTM figure through Mar 2026 stood at $1.3 billion (up 79.5% YoY), while the FY2025 annual figure was $1.3 billion, up 143.74% from the prior year.
• Tax Provisions was $265.0 million for Q1 2026 at Amgen, up from $181.0 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $705.0 million in Q3 2025 to a low of $45.0 million in Q1 2024.
• Historically, Tax Provisions has averaged $234.2 million across 5 years, with a median of $214.0 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Tax Provisions tumbled 92.51% in 2024, then jumped 440.0% in 2025.
• A 5-year view of Tax Provisions shows it stood at $132.0 million in 2022, then plunged by 35.61% to $85.0 million in 2023, then soared by 82.35% to $155.0 million in 2024, then gained by 16.77% to $181.0 million in 2025, then surged by 46.41% to $265.0 million in 2026.
• The last three Tax Provisions figures came in at $265.0 million (Q1 2026), $181.0 million (Q4 2025), and $705.0 million (Q3 2025), per Business Quant data.